A carregar...
Ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype in the Republic of Belarus
AIM OF THE STUDY: Aim of the study is to evaluate real-world efficacy of the ombitasvir/ paritaprevir/ ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype. MATERIAL AND METHODS: The study included 27 patients according to inclusion criteria. Main laboratory studies were...
Na minha lista:
| Publicado no: | Clin Exp Hepatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649486/ https://ncbi.nlm.nih.gov/pubmed/29062907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceh.2017.70281 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|